易瑞生物 (300942.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

现金流量表(易瑞生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 150,819,510.1899,637,270.1654,126,024.74763,455,135.13575,225,138.54458,563,038.10196,263,226.69
 收到的税费返还(元) 35,405,225.311,776,379.251,776,379.255,610,040.994,774,012.41192,043.83186,731.39
 收到其他与经营活动有关的现金(元) 16,341,906.1715,310,961.929,042,890.4017,024,010.2716,209,007.988,343,750.236,191,603.38
 经营活动现金流入小计(元) 202,566,641.66116,724,611.3364,945,294.39786,089,186.39596,208,158.93467,098,832.16202,641,561.46
 购买商品、接受劳务支付的现金(元) 66,196,777.8143,272,916.1426,785,160.70299,540,893.36276,798,711.93231,746,698.90137,851,780.90
 支付给职工以及为职工支付的现金(元) 91,254,175.1369,787,094.5742,298,780.09165,600,527.19109,449,737.3381,527,233.5847,336,582.91
 支付的各项税费(元) 26,903,885.7519,920,308.9912,742,105.6154,220,479.4953,004,143.3145,787,062.3011,012,354.36
 支付其他与经营活动有关的现金(元) 76,600,603.9655,512,664.1337,109,967.09114,172,754.38125,145,749.5591,564,439.8657,618,072.67
 经营活动现金流出小计(元) 260,955,442.65188,492,983.83118,936,013.49633,534,654.42564,398,342.12450,625,434.64253,818,790.84
 经营活动产生的现金流量净额(元) --71,768,372.50-152,554,531.97-16,473,397.52-
二、投资活动产生的现金流量
 收回投资收到的现金(元) ---500,001.00---
 取得投资收益收到的现金(元) 758,678.31360,328.77-6,572,341.828,781,622.427,501,395.796,566,466.36
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) 666,452.9920,000.0020,000.00541,000.00156,000.00156,000.00-
 收到其他与投资活动有关的现金(元) 418,000,000.00311,000,000.00181,000,000.00866,012,643.38678,800,000.00555,400,000.00431,000,000.00
 投资活动现金流入小计(元) 419,425,131.30311,380,328.77181,020,000.00873,625,986.20687,737,622.42563,057,395.79437,566,466.36
 购建固定资产、无形资产和其他长期资产支付的现金(元) 88,706,086.5365,502,239.3717,057,315.23176,848,588.75120,470,574.2943,917,618.8219,210,430.51
 投资支付的现金(元) 4,291,667.002,625,000.00-179,925,000.00179,925,000.0082,425,000.00-
 支付其他与投资活动有关的现金(元) 237,000,000.00222,000,000.00140,000,000.00706,800,000.00510,800,845.00490,800,000.00402,400,000.00
 投资活动现金流出小计(元) 329,997,753.53290,127,239.37157,057,315.231,063,573,588.75811,196,419.29617,142,618.82421,610,430.51
 投资活动产生的现金流量净额(元) 89,427,377.7721,253,089.4023,962,684.77-189,947,602.55-123,458,796.87-54,085,223.0315,956,035.85
三、筹资活动产生的现金流量
 取得借款收到的现金(元) 391,965,707.3248,331,552.251,192,830.0064,000,000.0064,000,000.0021,000,000.00-
 收到其他与筹资活动有关的现金(元) ---2,710,311.35---
 筹资活动现金流入小计(元) 391,965,707.3248,331,552.251,192,830.0066,710,311.3564,000,000.0021,000,000.00-
 偿还债务支付的现金(元) 2,560,000.001,280,000.001,280,000.002,560,000.001,280,000.00--
 分配股利、利润或偿付利息支付的现金(元) 11,707,750.3510,704,025.15581,803.56100,654,705.16100,135,231.6599,821,473.33-
 支付其他与筹资活动有关的现金(元) 12,160,720.1411,178,087.303,550,762.8917,343,301.9516,286,938.2410,693,058.14-
 筹资活动现金流出小计(元) 26,428,470.4923,162,112.455,412,566.45120,558,007.11117,702,169.89110,514,531.47-
 筹资活动产生的现金流量净额(元) 365,537,236.8325,169,439.80-4,219,736.45-53,847,695.76-53,702,169.89-89,514,531.47-
四、汇率变动对现金及现金等价物的影响(元) 4,794,538.887,260,250.03-1,135,290.77-809,008.1011,707,168.685,709,177.00-26,977.85
五、现金及现金等价物净增加额(元) 401,370,352.49-18,085,593.27-35,383,061.55-92,049,774.44-133,643,981.27-121,417,179.98-35,248,171.38
 加:期初现金及现金等价物余额(元) 247,180,686.63247,180,686.63247,180,686.63339,230,461.07339,230,461.07339,230,461.07339,230,461.07
 期末现金及现金等价物余额(元) 648,551,039.12229,095,093.36211,797,625.08247,180,686.63205,586,479.80217,813,281.09303,982,289.69
补充资料:
 净利润(元) --69,675,890.25-82,663,795.37-151,359,564.88-
 资产减值准备(元) --11,936,596.69-52,200,464.27-2,852,697.45-
 固定资产和投资性房地产折旧(元) -5,466,464.73-9,638,069.33-3,793,375.20-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) -5,466,464.73-9,638,069.33-3,793,375.20-
 无形资产摊销(元) -938,474.38-1,825,985.12-885,350.23-
 长期待摊费用摊销(元) -8,080,616.34-4,838,417.53-1,976,257.98-
 处置固定资产、无形资产和其他长期资产的损失(元) --2,134,806.62--300,542.68---
 固定资产报废损失(元) ---6,010.51-1,024.34-
 公允价值变动损失(元) --152,070.07---3,666,729.56-
 财务费用(元) --8,283,005.05-3,176,820.21--6,294,067.78-
 投资损失(元) -5,134,534.80--2,676,204.89--6,873,850.25-
 递延所得税(元) --14,319,162.46--7,503,512.23--4,665,430.89-
  其中:递延所得税资产减少(元) --14,319,162.46--7,503,512.23--4,896,677.71-
 递延所得税负债增加(元) -----231,246.82-
 存货的减少(元) -32,283,599.16--51,134,998.39--126,677,107.86-
 经营性应收项目的减少(元) -12,739,340.80--29,252,467.92--76,808,278.83-
 经营性应付项目的增加(元) --50,892,992.74-33,379,348.61-38,939,127.17-
 其他(元) -12,232,224.53-36,796,823.71-26,807,855.00-
 现金的期末余额(元) -229,095,093.36-247,180,686.63-217,813,281.09-
 减:现金的期初余额(元) -247,180,686.63-339,230,461.07-339,230,461.07-
 现金及现金等价物的净增加额(元) --18,085,593.27--92,049,774.44--121,417,179.98-
公告日期 2023-10-272023-08-302023-04-262023-04-262022-10-282022-08-302022-04-27
审计意见(境内) 标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院